drugset / Trial / NCT00817765

Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir

NCT00817765

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine the influence of posaconazole on unboosted fosamprenavir pharmacokinetics, and vice versa, in healthy volunteers.A second objective is to determine the safety of combined use of fosamprenavir with posaconazole in healthy volunteers.

Timeline

Start
2009-01
Primary completion
2009-07
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosamprenavir Small molecule 700 mg Oral
Subject Posaconazole Small molecule 400 mg Oral
Comparator Ritonavir Other / unclassified 100 mg Oral